Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.
| Analyst | Firm | Questions · challengingPercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| Jash Patwa | JPMorgan | 17 questions · 6% challenging |
| Bob Labick | CJS Securities | 16 questions · 6% challenging |
| Craig Kennison | Robert W. Baird | 13 questions · 8% challenging |
| Bret Jordan | Jefferies | 12 questions · 8% challenging |
| Chris Bottiglieri | BNP Paribas | 11 questions · 18% challenging |
| John Healy | Northcoast Research | 9 questions · 11% challenging |
| Jeff Lick | Stephens | 8 questions · 0% challenging |
| John Babcock | Barclays | 2 questions · 0% challenging |
| Firm | Analysts | Questions · challengingPercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| JPMorgan | 1 analyst | 17 questions · 6% challenging |
| CJS Securities | 1 analyst | 16 questions · 6% challenging |
| Robert W. Baird | 2 analysts | 14 questions · 7% challenging |
| Jefferies | 1 analyst | 12 questions · 8% challenging |
| BNP Paribas | 1 analyst | 11 questions · 18% challenging |
| Northcoast Research | 1 analyst | 9 questions · 11% challenging |
| Stephens | 1 analyst | 8 questions · 0% challenging |
| Barclays | 1 analyst | 2 questions · 0% challenging |
Copart reported Q2 consolidated revenue declining 3.6% year-over-year to $1.12 billion, with earnings per diluted share decreasing 9.2% to $0.36. Operating income declined 8.8% to $388.7 million, partly impacted by a $6.8 million one-time international VAT accrual. Insurance volume headwinds persisted while total loss frequency reached 24.2%. The company initiated a share buyback program with $500 million deployed and deployed AI at scale, though the revenue impact remained unclear.
Demand | Competitive Dynamics | Innovation & R&D | Pricing | Macroeconomic | Capex Investment | Revenue Growth | Geographic Expansion | |
|---|---|---|---|---|---|---|---|---|
| 2025Q1 | 5 | 6 | 1 | 1 | 1 | 2 | 1 | |
| 2025Q2 | 2 | 5 | 2 | 1 | 2 | 2 | 4 | |
| 2025Q3 | 5 | 3 | 1 | 1 | 2 | |||
| 2025Q4 | 8 | 4 | 4 | 1 | 2 | |||
| 2026Q1 | 8 | 5 | 1 | 3 | 2 | 1 | 1 | |
| 2026Q2 | 6 | 5 | 2 | 1 | 2 | 1 | 1 | |
| 2026Q3 | 4 | 3 | 1 | 2 | 2 | 4 | 2 |
| '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | '26Q2 | '26Q3 | |
|---|---|---|---|---|---|---|---|
| Demand | 5 | 2 | 5 | 8 | 8 | 6 | 4 |
| Competitive Dynamics | 6 | 5 | 3 | 4 | 5 | 5 | 3 |
| Innovation & R&D | 1 | 2 | 4 | 1 | 2 | 1 | |
| Pricing | 1 | 1 | 1 | 1 | 3 | 1 | 2 |
| Macroeconomic | 1 | 1 | 2 | 2 | 2 | 2 | |
| Capex Investment | 2 | 2 | 2 | 1 | 1 | ||
| Revenue Growth | 2 | 1 | 1 | 4 | |||
| Geographic Expansion | 1 | 4 | 2 |
No 8-K events recorded for this window.
What CPRT said about other companies on its FY2026 Q2 call, and what other companies said about CPRT on their calls covering the same calendar quarter (Q1 2026). Each company's own fiscal quarter is shown next to its name. Extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“industry-wide vehicle values have normalized somewhat from the elevated levels we observed during supply constrained -- supply chain constrained period of 2021 and 2022 as evidenced by Manheim indices and otherwise.”
Copart cites the Manheim indices as the industry benchmark evidencing that used-vehicle values have normalized from their 2021-2022 highs.
Calendar quarter Q1 2026Earnings call Feb 19, 2026
FY2026 Q2 in brief
Copart reported Q2 consolidated revenue declining 3.6% year-over-year to $1.12 billion, with earnings per diluted share decreasing 9.2% to $0.36.
Newest quarter FY2026 Q4 is part of Pro · see what Pro adds →
Sources. Tellvest earnings-call sentiment score for Copart (CPRT), FY2026 Q2: 3/10. Scores: Copart’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: CPRT daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2025 Q1 | $1.15B | +12.4% | $0.37 | +8.8% | 35.4% | 31.6% | $246M |
| FY2025 Q2 | $1.16B | +14.0% | $0.40 | +21.2% | 36.6% | 33.3% | $61M |
| FY2025 Q3 | $1.21B | +7.5% | $0.42 | +7.7% | 37.3% | 33.6% | $573M |
| FY2025 Q4 | $1.13B | +5.2% | $0.41 | +24.2% | 36.7% | 35.2% | $351M |
| FY2026 Q1 | $1.16B | +0.7% | $0.41 | +10.8% | 37.3% | 35.0% | $427M |
| FY2026 Q2Selected | $1.12B | -3.6% | $0.36 | -10.0% | 34.7% | 31.3% | $58M |
| FY2026 Q3 | $1.24B | +2.1% | $0.43 | +2.4% | 37.5% | 32.5% | $503M |
| FY2026 Q4 | $1.15B | +2.4% | $0.35 | -14.6% | 32.0% | 28.4% | $279M |
Management’s own words, often on a non-GAAP, constant-currency, or adjusted basis — so these can differ from the GAAP figures above (e.g. constant-currency revenue growth excludes currency swings).
GAAP revenue YoY -3.58% → base 4. The base score is anchored to the GAAP revenue YoY band before transcript, EPS, and guidance adjustments.
| Company | Score | Trend | Rev YoY | Headline |
|---|---|---|---|---|
| CPRTCopart | 3 | -3.6% | Revenue Declines as Insurance Volume Headwinds Persist | |
| CTASCintas | 8 | +8.9% | Record Revenue With All-Time High Gross Margins Across All Route-Based Businesses | |
| GPNGlobal Payments | 7 | +23.1% | Q1 Results Exceeded Expectations Post-Worldpay Close | |
| TRIThomson Reuters Corporation | 7 | +9.8% | Total company organic revenues accelerated to 8% growth from 7% throughout 2025, with legal professionals ex-government surging to 11% driven by the fiduciary-grade AI differentiation strategy |
Revenue Declines as Insurance Volume Headwinds Persist
Record Revenue With All-Time High Gross Margins Across All Route-Based Businesses
Total company organic revenues accelerated to 8% growth from 7% throughout 2025, with legal professionals ex-government surging to 11% driven by the fiduciary-grade AI differentiation strategy
| Company | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|---|
| CPRT | 6 | 7 | 6 | 7 | 6 | 3 |
| CTAS | 8 | 8 | 7 | 8 | 8 | 8 |
| GPN | 7 | 7 | 7 | 7 | 6 | 7 |
| TRI | 6 | 5 | 5 | 6 | 6 | 7 |